OBJECTIVE: Subjects born small for gestational age (SGA) who are prone to develop insulin resistance in adulthood display an abnormal development pattern of the adipose tissue during fetal and postnatal life. Since the lipolytic activity of the adipose tissue is critical in the development of insulin resistance, the purpose of this study was to investigate whether SGA itself might affect lipolysis regulation. STUDY DESIGN: We studied the effect of catecholamines, by local injection of isoproterenol, and the effect of insulin, using twostep infusion at 8 and 40 mU/m 2 /min, on the in situ lipolysis of the subcutaneous abdominal adipose tissue of 23 subjects born SGA and 23 born appropriate for gestational age (AGA), using the microdialysis technique. RESULTS: Under isoproterenol infusion, the increase in dialysate glycerol concentration was significantly 1.5-fold higher in the SGA than in the AGA group (P ¼ 0.02) and induced a 20% increase in the plasma FFA concentration (P ¼ 0.04), whereas no significant increase was observed in the AGA group. The antilipolytic action of insulin on dialysate glycerol concentration was similar in both groups throughout the insulin infusion. CONCLUSION: Subjects born SGA demonstrated a hyperlipolytic reactivity to catecholamines, which might be regarded as an additional deleterious component of the insulin resistance associated with SGA. In contrast, being born SGA does not directly affect the antilipolytic action of insulin, showing that it does not play a major role in causing the long-term metabolic complications associated with reduced fetal growth.
Introduction
Subjects born small for gestational age (SGA) who are prone to develop insulin resistance in adulthood [1] [2] [3] [4] [5] display an abnormal development pattern of the adipose tissue during fetal and postnatal life by showing a dramatically reduced body fat mass at birth and, in the large majority of them, a catch-up growth process during infancy and childhood involving the adipose tissue. [6] [7] [8] Since adipose tissue plays a key role in the development and the worsening of insulin resistance, 9, 10 this very peculiar pattern of development of the adipose tissue itself might contribute to the later development of insulin resistance. The contribution of the adipose tissue in the pathophysiology of insulin resistance is mostly based on its lipolytic activity, resulting in free fatty acids (FFA) production and mobilization, 11, 12 which has been largely documented to be deleterious on glucose utilization and insulin action. 12, 13 In humans, insulin and catecholamines are the major hormonal regulators of the lipolytic activity. 14, 15 How restricted fetal growth itself might affect lipolysis regulation in adulthood appears therefore a critical step to unravel the mechanisms by which restricted fetal growth affect insulin sensitivity in adulthood. To achieve this goal, we have investigated the in situ effects of insulin and catecholamines on the lipolysis of the subcutaneous abdominal adipose tissue in young lean adults born SGA compared to subjects born appropriate for gestational age (AGA), using the microdialysis technique.
Subjects and methods

Subjects
A total of 46 subjects born either SGA or AGA were recruited from the regional cohort of Haguenau in which subjects had been selected on birth data. 2 All subjects were of Caucasian origin. SGA was defined as a birth weight below the 10th percentile of the local distribution for gender and gestational age. 16 The AGA group was made of subjects with size at birth between the 25th and the 75th percentiles of the same distribution. Inclusion criteria included BMI o27 kg/m 2 and normal glucose tolerance according to the WHO criteria.
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Clinical characteristics of the two groups at birth and at the time of the study are summarized in Table 1 . As expected, mean birth sizes for gestational age were significantly reduced in the SGA group. At the time of the study, mean body weight, height, BMI and waist-to-hip ratio did not significantly differ between the two groups, but the percentage of total body fat mass was significantly higher in the SGA group. Parental history of type-2 diabetes was comparable in both groups (2/23 vs 0/23, P ¼ 0.48). Six out of 10 women born SGA were under oral contraception vs five out of nine in the AGA women (P ¼ 0.90). Smoking habit was observed in 9/23 subjects born SGA vs 7/23 controls (P ¼ 0.76).
All subjects gave their written informed consent and the study protocol was reviewed and approved by the Ethics committee of the University of Paris/St Louis.
Study design
Subjects were admitted to the Clinical Investigation Unit at the Robert Debré hospital (Paris). Body. fat mass was determined with dual X-ray absorbtiometry (GE medical system, Lunar). Figure 1 illustrates the study protocol. Metabolic investigations were performed after an overnight fast. Two microdialysis probes (CMA microdialysis AB, Stockholm, Sweden) were inserted percutaneously into the subcutaneous adipose tissue at both sides of the umbilicus (8cm). The probes were continuously infused with Ringer's solution (BAXTER, Maurepas, France) at 5 ml/min during 5 min and 0.6 ml/min for a 30 min equilibration period. Immediately after the equilibration period, one of the two probes was infused with a Ringer's solution supplemented with 10 À6 mol/l isoproterenol at 0.6 ml/ min during 30 min (stimulated probe (SP)), whereas the other one remained continuously infused with a Ringer's solution alone (reference probe (RP)).
A two-steps insulin infusion 18 was started 30 min after the end of the isoproterenol infusion (washout period). Insulin was infused during the first 100 min at a dose of 8 mU/m 2 / min (Ins1 period) and was continued for a further 100 min period at a dose of 40 mU/m 2 /min (Ins 2 period). Plasma glucose concentrations were maintained at 5.575 mmol/l throughout the test using a 20% glucose infusion. During the Ins1 period, steady-state serum insulin levels were at 63722 and 84736 pmol/l in the SGA and AGA groups, respectively (P ¼ 0.10). During the Ins 2 period, steady-state serum insulin levels were attained at 360760 and 318766 pmol/l in the SGA and AGA groups, respectively (P ¼ 0.12).
A first sample of dialysate was collected 15 min after the insertion of the probes but not analyzed. Basal concentrations of glycerol were measured on the dialysates collected between 15 and 30 min after the initiation of the equilibration period and every 20 min thereafter. Results are expressed as means (s.d.). Anthropometric parameters at birth were compared after adjustment for gender and gestational age. Anthropometric parameters at the time of the study were compared after adjustment for current age and gender. Lipolytic regulation in subjects born SGA J Boiko et al Plasma FFA were measured at fasting, 30 min after the end of the isoproterenol infusion and every 20 min during the clamp.
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Analytical methods
Plasma glucose concentrations during the clamp were measured by the glucose oxidase method on an on-site Beckman analyzer (Beckman instruments, Fullerton, USA). Plasma insulin concentrations were measured using a doubleantibody radio-immuno-assay (ERIA Diagnostics Pasteur, France). Crossreactivity with proinsulin and derived metabolites was less than 1%. Assay sensitivity was 1.2 pmol/l and intra-and interassays coefficients of variations were 3.8 and 8% at 48 pmol/l, respectively, and 2.4 and 4.8% at 300 pmol/l, respectively.
Glycerol concentrations in the dialysates were measured using a colorimetric technique with a microdialysis analyzer (CMA/Microdialysis AB, Stokholm, Sweden). Plasma FFA concentrations were measured using a commercial enzymatic kit (NEFAC WAKO, OXOID, Dardilly, France).
Statistical analyses
All analyses were performed using the SAS statistical package. (SAS Institute, Meylan, France). For qualitative variables, the association between SGA/AGA was tested using a w 2 test.
Differences between the two groups in anthropometric parameters were tested after adjustment for gender and gestational age for birth parameters and age at the time of the study for current parameters using a GLM procedure (general linear model). Changes in FFA and glycerol concentrations induced by isoproterenol and insulin infusion within each group were tested using the paired nonparametric Wilcoxon test. Relative variations in glycerol and FFA induced by isoproterenol and insulin infusion were calculated as the difference between the final and basal concentrations divided by the basal concentration. Circulating insulin and FFA concentrations and dialysate glycerol concentrations were log-transformed to remove positive skewness. Differences in the relative variation in glycerol and FFA induced by isoproterenol and insulin infusion were tested using a GLM procedure after adjustment for gender and body fat mass. Statistical significance was taken at Pr0.05.
Results
Basal state
Neither dialysate glycerol concentrations (2387108 vs 202774 pmol/l, P ¼ 0.94) nor plasma FFA concentrations (5357198 vs 4697157 mmol/l, P ¼ 0.65) significantly differed between the SGA and the AGA groups. Gender had no effect either on the fasting FFA concentration (P ¼ 0.24) or on the fasting dialysate glycerol concentration (P ¼ 0.40). In contrast, fasting dialysate glycerol and plasma FFA concentrations were positively correlated with the percentage of total body fat although the effect did not reach statistical significance for FFA concentrations (P ¼ 0.04 and P ¼ 0.09, respectively). When percentage of total body fat mass was taken into account, the difference between the two groups remained nonsignificant. Figure 2 illustrates the variations in dialysate glycerol and in plasma FFA concentrations after isoproterenol infusion. Both groups showed a significant increase in dialysate glycerol concentrations under isoproterenol stimulation. However, this increase was significantly more pronounced in the SGA group than in the AGA group (P ¼ 0.02). The local stimulation of the abdominal subcutaneous adipose tissue by isoproterenol induced a 20% significant increase in plasma FFA concentration in the SGA group (P ¼ 0.04), whereas this was not the case in the AGA group (Figure 2 ). The percentage of total body fat mass negatively influenced the relative variation in dialysate glycerol concentration (P ¼ 0.03), but had no effect on the variation in FFA concentration.
Lipolytic effect of isoproterenol
Antilipolytic effect of insulin
At baseline, both fasting serum insulin levels (28714 vs 1978 pmol/l, P ¼ 0.04) and fasting insulin-to-glucose ratios (6.173.0.10 À9 vs 4.171.5.10
À9
, P ¼ 0.03) were significantly higher in the SGA group than in the AGA group. The local antilipolytic effect of insulin on the abdominal subcutaneous adipose tissue was tested on the RP and after local infusion of isoproterenol (SP). Figure 3 illustrates the variations of dialysate glycerol concentrations within each probe during the test. Lipolytic regulation in subjects born SGA J Boiko et al
In the RP, low dose of insulin (8 mU/m 2 /min, Ins1 period) significantly decreased the dialysate glycerol concentration by 8% in both groups. The high dose of insulin (40 mU/m 2 / min, Ins 2 period) induced significant and comparable effects in both groups by decreasing the dialysate glycerol levels by 29%. At steady state under this insulin dosage, the peripheral glucose uptake was significantly lower in the SGA than in the AGA group (8.973.5 vs 11.173.1 mg/kg fat-freemass/min, P ¼ 0.04) Under prestimulated condition (SP), the decrease of glycerol production was of greater magnitude than under basal condition but comparable in both groups: around 30-40% of decrease during the Ins1 period and 60% of decrease during the Ins 2 period.
Similarly, no significant differences were observed between the SGA and AGA groups in the degree of plasma FFA suppression, either during the Ins1 period (À66718 vs À71710%, P ¼ 0.25) or during the Ins 2 period (À8778 vs À8776%, P ¼ 0.33).
Discussion
By studying the regulation of lipolysis in vivo using the microdialysis technique, we were able to evidence an increased lipolytic response to b-adrenergic stimulation in the subcutaneous abdominal adipose tissue of young adults born SGA. Overall, isoproterenol increased local glycerol production in both groups, but the effect was 1.5-fold more pronounced in the SGA group than in the AGA group. Yet, subjects born SGA demonstrated significantly higher percentage of total body fat mass which negatively influences the lipolytic action of isoproterenol; when total body fat mass was taken into account, the difference between the two groups became even higher ( Â 1.8). In the SGA group, this increased lipolytic response to catecholamines was associated with a 20% increase in plasma FFA concentration, whereas no such a significant elevation was observed in the AGA group. These observations are consistent and suggest that the adipose tissue of subjects born SGA demonstrates hyper-reactivity to b adrenergic action of catecholamines. Lipolytic regulation in subjects born SGA J Boiko et al
The elevation of plasma FFA concentrations observed under local administration of isoproterenol in the SGA group was unexpected given the small area of adipose tissue involved by the microdialysis technique and the small amount of isoproterenol infused in this area. Although this observation remains difficult to explain, it might result from a difference in the local diffusion of isoproterenol in the adipose or in the architecture of the tissue itself between subjects born AGA or SGA allowing a greater diffusion in this latter group. These data provide an additional example of alteration in regulatory mechanisms involving the sympathetic nervous system (SNS) as a consequence of reduced fetal growth. Indeed previous data reported in humans and in animal models have demonstrated that SGA is associated with an increased SNS activity, especially in the cardiovascular system. 19, 20 Considering the role of SNS on the adaptation to stress and starvation, 22, 23 reduced fetal growth might induce adaptative changes in the SNS activity, at least during the fetal and neonatal periods; this adaptation would reduce energetic expenditure and supply endogenous energetic substrates by increasing lipolysis. This increased lipolytic activity in response to catecholamines could therefore be regarded as the persistence throughout the postnatal life of an adaptative response to reduced fetal growth, according to the programming theory. 24 However, this hypothesis does not seem compatible with the relative increased body fat mass observed in subjects born SGA. Indeed, it has been shown that the catch-up growth phenomenon is characterized by accelerated fat recovery leading to excess in body fat mass relative to lean body mass, but with no subsequent obesity. 8, 25, 26 This phenomenon is restricted to reduced fetal growth but commonly observed in different situations of weight fluctuation involving weight recovery after weight loss. 21 A persistent increased lipolytic activity would impede the fat recovery. Although adaptation to starvation is mainly under the control of SNS, catch-up fat recovery is rather under the control of the adipose tissue itself. 21 It cannot therefore be ruled out that during catch-up growth, the two pathways coexist. Moreover, lipolytic hyperactivity would even counteract to some extent catch-up fat and protect against obesity. Nevertheless, only the study of lipogenesis and lipolytic regulation during the catch-up growth process would help to clarify the origin of this increased lipolytic reactivity to catecholamines in subjects born SGA. Whether this hyperlipolytic response to catecholamines is involved in the pathophysiology of the metabolic syndrome associated with SGA must now be discussed. There are accumulating evidences pointing to the role of the sympathetic nervous system in the clustering of anthropometric, cardiovascular and metabolic abnormalities in the metabolic syndrome, even though the precise mechanisms by which the sympathetic nervous system is involved is not clearly elucidated as yet. [27] [28] [29] From a metabolic point of view, it can be speculated that the greater reactivity might result in increased FFA production in subjects born SGA, increasing thereby the circulating FFA known to be deleterious in the control of insulin sensitivity. 11, 12 Furthermore, regarding the interplay between insulin and catecholamines in the adipocyte lipolytic regulation, it has been shown that the magnitude of the lipolytic effect induced by catecholamines overrides the antilipolytic effect of insulin. 30, 31 This is clearly evidenced in the present study by the pattern of glycerol production in the two probes. While the SGA and AGA curves were highly similar in the reference probe illustrating insulin action under basal conditions, the increased glycerol production induced by isoproterenol in the SGA group had never been totally leveled down under insulin administration in the prestimulated probe. Finally, it has been shown that catecholamines suppress leptin release via b1 and b2 adrenoreceptors. 32, 33 Considering the increased lipolysis responsiveness to catecholamines, it cannot be ruled out that a comparable hypersensitivity to catecholamines-induced inhibition of leptin might explain, at least in part, the lower levels of serum leptin concentrations previously observed in subjects born SGA, which in turn might be regarded as an additional deleterious component in the control of insulin sensitivity. 26 Studying the lipolytic response to catecholamines in clearly insulin-resistant subjects born SGA in comparison to insulin-sensitive ones would certainly help to clarify the relationship between these two metabolic abnormalities in this specific clinical situation. Under insulin stimulation, no significant difference in the degree of local glycerol suppression was evidenced between the SGA and the AGA groups, either on the reference probe or on the prestimulated probe. By amplifiyng the magnitude of the response to insulin, the latter condition would therefore allow evidencing small alteration in the antilipolytic action of insulin in the SGA group if any. This would have not been possible in the reference probe because of the small variations in glycerol concentrations induced by insulin on basal condition. However, the magnitudes of the responses were comparable in both groups at the two doses of insulin and in the two probes, reflecting therefore a comparable insulin sensitivity of the adipose tissue. Nevertheless, two points must be underlined in the interpretation of these observations. First of all, a high interindividual variability was observed in the glycerol responses measured with the microdialysis technique, making it difficult to evidence minor alteration. Additionally, the maximum local antilipolytic response to insulin was not assessed with these two doses of insulin. Since FFA suppression during the test was comparable between the two groups and attained expected values at the two doses of insulin (60% during the first period and 85% during the second period), it can be concluded that reduced fetal growth itself does not directly affect the antilipolytic action of insulin. However, whether insulinresistance differently affect adipose tissue lipolysis when associated with SGA needs to be further documented in order to precisely elucidate the contribution of lipolysis regulation in the long-term metabolic complication associated with reduced fetal growth.
Lipolytic regulation in subjects born SGA J Boiko et al In summary, subjects born SGA demonstrated a hyperlipolytic activity in response to catecholamines as evidenced in situ with the microdialysis technique. The origin of this increased adrenergic lipolytic responsiveness remains unclear, but it could play a deleterious role in the control of insulin sensitivity in subjects born SGA. In contrast, being born SGA does not seem to directly affect the antilipolytic action of insulin, excluding it as a primary component in the pathophysiology of the long-term metabolic complications associated with reduced fetal growth.
